Since secreted Fas ligand, which is increased in the serum of patients affected by T-LGL leukemia [20–22], has been hypothesized to play a role in inducing neutropenia in these patients [16], we evaluated Fas ligand expression in our series of patients subdivided according to their immunophenotype. The gene discussed is FASLG; the disease is neutropenia.